The official journal of CSACI
Articles
Page 24 of 26
-
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P13
-
Comorbidity with depression and overweight in children with asthma
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P10 -
Food allergy management from the perspective of patients, caregivers and allergists: a qualitative study
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P8 -
Quality of penicillin allergy management in the intensive care unit and internal medicine ward
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P1 -
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of ...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:28 -
Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study
Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with puri...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:27 -
The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists
Despite over a century of clinical use and a well-documented record of efficacy and safety, a growing minority in society questions the validity of vaccination and fear that this common public health intervent...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:26 -
Eotaxin and FGF enhance signaling through an Extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Syste...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:25 -
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:24 -
HAE therapies: past present and future
Advances in understanding the pathophysiology and mechanism of swelling in hereditary angioedema (HAE) has resulted in the development of multiple new drugs for the acute and prophylactic treatment of patients...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:23 -
HAE international home therapy consensus document
Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:22 -
On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.
Citation: Allergy, Asthma & Clinical Immunology 2010 6:21 -
Management of hereditary angioedema: 2010 Canadian approach
C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadi...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:20 -
Management of upper airway edema caused by hereditary angioedema
Hereditary angioedema is a rare disorder with a genetic background involving mutations in the genes encoding C1-INH and of factor XII. Its etiology is unknown in a proportion of cases. Recurrent edema formatio...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:19 -
Pediatric hereditary angioedema due to C1-inhibitor deficiency
Hereditary angioedema (HAE) resulting from the deficiency of the C1 inhibitor (C1-INH) is a rare, life-threatening disorder. It is characterized by attacks of angioedema involving the skin and/or the mucosa of...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:18 -
Hereditary angioedema in women
Women with hereditary angioedema (HAE) are more likely to be symptomatic that men. Hormonal factors (puberty, contraception, pregnancy,....) play a significant role in the precipitation or worsening of the con...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:17 -
Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions
The clinical, biochemical and genetic features of the conditions known as estrogen-dependent inherited angioedema, estrogen-associated angioedema, hereditary angioedema with normal C-1 inhibitor, type III angi...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:16 -
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
Until recently it was assumed that hereditary angioedema is a disease that results exclusively from a genetic deficiency of the C1 inhibitor. In 2000, families with hereditary angioedema, normal C1 inhibitor a...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:15 -
Acquired angioedema
Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released ...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:14 -
Hereditary Angioedema Consensus 2010
Citation: Allergy, Asthma & Clinical Immunology 2010 6:13 -
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review
Primary immune deficiency disorders (PIDs) are a group of diseases associated with a genetic predisposition to recurrent infections, malignancy, autoimmunity and allergy. The molecular basis of many of these d...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:12 -
Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter
Hereditary Angioedema (HAE) is a rare, autosomal dominant (AD) disorder caused by a C1 esterase inhibitor (C1-inh) deficiency or qualitative defect. Treatment of HAE in many parts of the world fall short and c...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:11 -
Rhinitis in the geriatric population
The current geriatric population in the United States accounts for approximately 12% of the total population and is projected to reach nearly 20% (71.5 million people) by 2030[1]. With this expansion of the numbe...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:10 -
Clinical experience in T cell deficient patients
T cell disorders have been poorly understood until recently. Lack of knowledge of underlying molecular mechanisms together with incomplete data on long term outcome have made it difficult to assess prognosis a...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:9 -
Characteristics of anaphylaxis in a pediatric emergency department (ED): does management follow published guidelines?
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P33 -
Onset of action of loratadine/montelukast combination in subjects with seasonal allergic rhinitis in the environmental exposure unit
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P29 -
Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P27 -
Adjunctive treatment of chronic idiopathic urticaria and angioedema with sulfasalazine
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P25 -
A dramatic case of non-episodic angioedema with eosinophilia
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P23 -
Rifampin hypersensitivity in a two year-old child with successful rapid oral desensitization
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P22 -
Effects of nitric oxide-induced aldolase nitration on the glycolytic metabolites of mast cell
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P21 -
Interleukin-33 in asthma: insights into pro-inflammatory roles of airway structural cells
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P20 -
Local Toll-like receptor-mediated mast cell activation inhibits melanoma growth
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P19 -
Does IgE-mediated mast cell activation reduce oral tolerance to food antigens?
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P18 -
Atopy affects LPS responsiveness and TLR-4 expression in children peripheral mononuclear cells
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P17 -
Differential effects of C5a on human and mouse mast cells may be mediated by C5aR and C5L2
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P16 -
Human mast cells respond to viral infection by recruiting NK cells and T cells
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P15 -
Comparison of the inhibitory effects of resveratrol and tranilast on IgE, 48/80 and substance P dependent-mast cell activation
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P14 -
Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P13 -
Effectiveness study of an online anaphylaxis training program for school personnel: overview of methods for a pilot study in a large Canadian school board
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P12 -
Assessing a population-based approach to the management of respiratory disease
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P11 -
Are teachers knowledgeable and confident about dealing with allergy emergencies?
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P10 -
Assessing a community-based asthma education intervention
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P9 -
Long-term safety of inhaled corticosteroids in children
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P7 -
Asthma control – components and clinical importance
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P6 -
The impact of participation in the SAGE study on parent behavior
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P5 -
Likelihood of adrenaline auto-injectors being mis-prescribed by primary care physicians
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P4 -
Early life nutrition, the developing immune system and subsequent allergic manifestations
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P3 -
Oilseed rape allergy: is it significant? An investigation into its prevalence in an East Anglian population, UK
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P2 -
Likelihood of Stachybotyrs atra sensitization in Canadian populations
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P1
Annual Journal Metrics
-
Citation Impact
3.373 - 2-year Impact Factor (2021)
3.776 - 5-year Impact Factor (2021)
1.093 - Source Normalized Impact per Paper (SNIP)
0.747 - SCImago Journal Rank (SJR)Speed
60 days to first decision for all manuscripts (Median)
61 days to first decision for reviewed manuscripts only (Median)Usage
1,430,350 Downloads (2021)
1,262 Altmetric mentions (2021)